Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment source : Investors.biomarin.com save search
BioMarin Announces the Ministry of Health, Labor and Welfare (MHLW) in Japan Granted Approval for VOXZOGO® (vosoritide) for Injection for the Treatment of Children with Achondroplasia, Whose Growth Plates are Not Closed
Published: 2022-06-21 (Crawled : 20:00) - investors.biomarin.com
BMRN | $91.415 -0.7% 1.1M
|
Health Technology
|
| O: 0.66%
H: 6.95%
C: 4.08%
voxzogo treatment japan children granted approval injection growth achondroplasia
BioMarin Receives Positive CHMP Opinion in Europe for Vosoritide for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Published: 2021-06-25 (Crawled : 12:00) - investors.biomarin.com
BMRN | $91.415 -0.7% 1.1M
|
Health Technology
|
| O: 0.66%
H: 1.39%
C: 0.55%
treatment europe drop positive children growth chmp achondroplasia
European Medicines Agency Grants BioMarin's Request for Accelerated Assessment of Valoctocogene Roxaparvovec for Treatment of Severe Hemophilia A
Published: 2021-05-24 (Crawled : 13:00) - investors.biomarin.com
BMRN | $91.415 -0.7% 1.1M
|
Health Technology
|
| O: 0.67%
H: 0.36%
C: -1.36%
treatment europe granted grant
BioMarin Announces New and Updated Data at 2021 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting Demonstrating Commitment to Understanding Achondroplasia and Potential Treatment Choice
Published: 2021-04-15 (Crawled : 13:00) - investors.biomarin.com
ICLR | News | $307.65 0.39% 590K
|
Health Technology
|
| O: 1.5%
H: 3.57%
C: 2.92%
BMRN | $91.415 -0.7% 1.1M
|
Health Technology
|
| O: -1.94%
H: 3.81%
C: 2.68%
treatment genetic potential drop genomic achondroplasia
BioMarin Announces Oral Presentation at ENDO2021, the Endocrine Society's Annual Meeting, with Data Demonstrating 2 Years of Treatment Benefit in Children with Achondroplasia Treated with Vosoritide
Published: 2021-03-20 (Crawled : 16:20) - investors.biomarin.com
BMRN | $91.415 -0.7% 1.1M
|
Health Technology
| Email alert
Add to watchlist
presentation treatment drop endocrine children achondroplasia
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
SKIL 4 | $8.72 52.72% 410K
|
Information
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
RILY | $29.755 36.99% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.